This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
4BN Ames , MK Shigenaga & TM Hagen (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 90, 7915–7922.
5K Asplund (2002) Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review. J Intern Med 251, 372–392.
6R Clarke & J Armitage (2002) Antioxidant vitamins and risk of cardiovascular disease. Review of large-scale randomised trials. Cardiovasc Drugs Ther 16, 411–415.
7DP Vivekananthan , MS Penn , SK Sapp , (2003) Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361, 2017–2023.
8RS Eidelman , D Hollar , PR Hebert , (2004) Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med 164, 1552–1556.
9J Helmersson , B Vessby , A Larsson , (2004) Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 109, 1729–1734.
10S Bergström (1967) Prostaglandins: members of a new hormonal system. These physiologically very potent compounds of ubiquitous occurrence are formed from essential fatty acids. Science 157, 382–391.
12DA Willoughby (1975) Heberden Oration, 1974. Human arthritis applied to animal models. Towards a better therapy. Ann Rheum Dis 34, 471–478.
13DK Mutschler , MB Eriksson , BG Wikström , (2003) Microdialysis-evaluated myocardial cyclooxygenase-mediated inflammation and early circulatory depression in porcine endotoxemia. Crit Care Med 31, 1780–1785.
15S Basu (1998) Radioimmunoassay of 15-keto-13,14-dihydro-prostaglandin F2α: an index for inflammation via cyclooxygenase catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids 58, 347–352.
16S Basu & M Eriksson (1998) Oxidative injury and survival during endotoxemia. FEBS Lett 438, 159–160.
17JD Morrow , KE Hill , RF Burk , (1990) A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A 87, 9383–9387.
18MH Shishehbor , R Zhang , H Medina , (2006) Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease. Free Radic Biol Med 41, 1678–1683.
19S Basu & J Helmersson (2005) Factors regulating isoprostane formation in vivo. Antioxid Redox Signal 7, 221–235.
20J Helmersson , J Ärnlöv , B Vessby , (2005) Serum selenium predicts levels of F2-isoprostanes and prostaglandin F2α in a 27 year follow-up study of Swedish men. Free Radic Res 39, 763–770.
24J Helmersson & S Basu (1999) F2-isoprostane excretion rate and diurnal variation in human urine. Prostaglandins Leukot Essent Fatty Acids 61, 203–205.
25S Basu (2007) Novel cyclooxygenase-catalyzed bioactive prostaglandin F2α from physiology to new principles in inflammation. Med Res Rev 27, 435–468.
26J Helmersson , B Vessby , A Larsson , (2005) Cyclooxygenase-mediated prostaglandin F2α is decreased in an elderly population treated with low-dose aspirin. Prostaglandins Leukot Essent Fatty Acids 72, 227–233.
27A Smedman , B Vessby & S Basu (2004) Isomer-specific effects of conjugated linoleic acid on lipid peroxidation in humans: regulation by α-tocopherol and cyclo-oxygenase-2 inhibitor. Clin Sci (Lond) 106, 67–73.
29YT Szeto , TC Kwok & IF Benzie (2004) Effects of a long-term vegetarian diet on biomarkers of antioxidant status and cardiovascular disease risk. Nutrition 20, 863–866.
30WM van Herpen-Broekmans , IA Klopping-Ketelaars , ML Bots , (2004) Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation. Eur J Epidemiol 19, 915–921.
33DC McMillan , D Talwar , N Sattar , (2002) The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours. Clin Nutr 21, 161–164.
34CY Chang , JY Chen , D Ke , (2005) Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits. Nutrition 21, 987–993.
35G Block , C Jensen , M Dietrich , (2004) Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation. J Am Coll Nutr 23, 141–147.
36JE Upritchard , WH Sutherland & JI Mann (2000) Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 23, 733–738.
37M Tahir , B Foley , G Pate , (2005) Impact of vitamin E and C supplementation on serum adhesion molecules in chronic degenerative aortic stenosis: a randomized controlled trial. Am Heart J 150, 302–306.
39TP Erlinger , E Guallar , ER Miller III, (2001) Relationship between systemic markers of inflammation and serum α-carotene levels. Arch Intern Med 161, 1903–1908.
40P Hu , DB Reuben , EM Crimmins , (2004) The effects of serum β-carotene concentration and burden of inflammation on all-cause mortality risk in high-functioning older persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci 59, 849–854.
42L J Roberts II, JA Oates , MF Linton , (2007) The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic Biol Med 43, 1388–1393.
44M Reilly , N Delanty , JA Lawson , (1996) Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94, 19–25.
45ST Mayne , M Walter , B Cartmel , (2004) Supplemental β-carotene, smoking, and urinary F2-isoprostane excretion in patients with prior early stage head and neck cancer. Nutr Cancer 49, 1–6.
46S Basu (2006) F2-isoprostane induced prostaglandin formation in the rabbit. Free Radic Res 40, 273–277.
47PH Chan , M Yurko & RA Fishman (1982) Phospholipid degradation and cellular edema induced by free radicals in brain cortical slices. J Neurochem 38, 525–531.
48GN Rao , MS Runge & RW Alexander (1995) Hydrogen peroxide activation of cytosolic phospholipase A2 in vascular smooth muscle cells. Biochim Biophys Acta 1265, 67–72.
49U Senftleben & M Karin (2002) The IKK/NF-κB pathway. Crit Care Med 30, S18–S26.